<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">microcirculation</journal-id><journal-title-group><journal-title xml:lang="ru">Регионарное кровообращение и микроциркуляция</journal-title><trans-title-group xml:lang="en"><trans-title>Regional blood circulation and microcirculation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-6655</issn><issn pub-type="epub">2712-9756</issn><publisher><publisher-name>Academician I.P. Pavlov First St. Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1682-6655-2017-16-2-70-74</article-id><article-id custom-type="elpub" pub-id-type="custom">microcirculation-115</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ (КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ)</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES (CLINICAL INVESTIGATIONS)</subject></subj-group></article-categories><title-group><article-title>Окклюзия центральной вены сетчатки на фоне приема силденафила цитрата</article-title><trans-title-group xml:lang="en"><trans-title>Retinal vein occlusion after intake of sildenafil citrate</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тульцева</surname><given-names>С. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Tultseva</surname><given-names>S. N.</given-names></name></name-alternatives><email xlink:type="simple">Tultceva@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Титаренко</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Titarenko</surname><given-names>A. I.</given-names></name></name-alternatives><email xlink:type="simple">Aleksandra-titarenko@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нечипоренко</surname><given-names>П. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Nechiporenko</surname><given-names>P. A.</given-names></name></name-alternatives><email xlink:type="simple">Paul_because@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Первый Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Academician I. P. Pavlov First St. Petersburg State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>30</day><month>06</month><year>2017</year></pub-date><volume>16</volume><issue>2</issue><fpage>70</fpage><lpage>74</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Тульцева С.Н., Титаренко А.И., Нечипоренко П.А., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Тульцева С.Н., Титаренко А.И., Нечипоренко П.А.</copyright-holder><copyright-holder xml:lang="en">Tultseva S.N., Titarenko A.I., Nechiporenko P.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.microcirc.ru/jour/article/view/115">https://www.microcirc.ru/jour/article/view/115</self-uri><abstract><p>Приводится описание редкого возможного осложнения приема силденафила цитрата - окклюзии центральной вены сетчатки. Обсуждается влияние силденафила цитрата на регионарную и системную гемодинамику, а также роль предрасполагающих факторов (гипертоническая болезнь, гипергомоцистеинемия) и провоцирующих, проявляющихся в виде физической нагрузки, посещения сауны и двойной дозы регулятора потенции. Результатом воздействия провоцирующих факторов явилось резкое снижение регионарного перфузионного давления с развитием окклюзии центральной вены сетчатки.</p></abstract><trans-abstract xml:lang="en"><p>This article describes the case of a possible rare complication of sildenafil citrate use - central retinal vein occlusion. Sildenafil citrate influences on regional and systemic hemodynamics. The role of predisposing factors (arterial hypertension, hyperhomocysteinemia) and provoking factors (physical exercise, visiting sauna and a double dose of the potency regulator) is discussed. Combination of provoking factors including use of sildenafil citrate has resulted in acute decrease in regional perfusion pressure with the development of central retinal vein occlusion.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>окклюзия центральной вены сетчатки</kwd><kwd>силденафил цитрат</kwd><kwd>гипергомоцистеинемия</kwd><kwd>недостаточность цилио-ретинальной артерии</kwd><kwd>retinal vein occlusion</kwd><kwd>sildenafil citrate</kwd><kwd>hyperhomocysteinemia</kwd><kwd>cilioretinal arteriolar insufficiency</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Тульцева С. Н. Значение гипергомоцистеинемии в патогенезе ишемического тромбоза вен сетчатки // Офтальмолог. ведомости. 2008. № 1 (3). С. 31-40.</mixed-citation><mixed-citation xml:lang="en">Тульцева С. Н. Значение гипергомоцистеинемии в патогенезе ишемического тромбоза вен сетчатки // Офтальмолог. ведомости. 2008. № 1 (3). С. 31-40.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Тульцева С. Н., Астахов Ю. С., Титаренко А. И., Руховец А. Г. Суточный профиль артериального давления у пациентов с окклюзией вен сетчатки молодого и среднего возраста // Артериальная гипертензия. 2017.</mixed-citation><mixed-citation xml:lang="en">Тульцева С. Н., Астахов Ю. С., Титаренко А. И., Руховец А. Г. Суточный профиль артериального давления у пациентов с окклюзией вен сетчатки молодого и среднего возраста // Артериальная гипертензия. 2017.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Тульцева С. Н., Титаренко А. И., Руховец А. Г. Характеристика системной и регионарной гемодинамики при ишемической окклюзии вен сетчатки у лиц молодого и среднего возраста // Регионарное кровообращение и микроциркуляция. 2016. № 2(58). С. 24-31.</mixed-citation><mixed-citation xml:lang="en">Тульцева С. Н., Титаренко А. И., Руховец А. Г. Характеристика системной и регионарной гемодинамики при ишемической окклюзии вен сетчатки у лиц молодого и среднего возраста // Регионарное кровообращение и микроциркуляция. 2016. № 2(58). С. 24-31.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Azzouni F., Abu K. Are phosphodiesterase type 5 inhibitors associated with vision-threating adverse events? A critical analysis and review of the literature // J. Sex Med. 2011. № 8. Р. 2894-2903.</mixed-citation><mixed-citation xml:lang="en">Azzouni F., Abu K. Are phosphodiesterase type 5 inhibitors associated with vision-threating adverse events? A critical analysis and review of the literature // J. Sex Med. 2011. № 8. Р. 2894-2903.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Browning D. J. Patchy ischemic retinal whitening inacute central retinal vein occlusion // Ophthalmology. 2002. № 109. Р. 2154-2159.</mixed-citation><mixed-citation xml:lang="en">Browning D. J. Patchy ischemic retinal whitening inacute central retinal vein occlusion // Ophthalmology. 2002. № 109. Р. 2154-2159.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Chruscicki D. A., Sutton S., Sutton L. Branch retinal artery occlusion associated with sildenafil citrate // Retinal Physician. 2011.</mixed-citation><mixed-citation xml:lang="en">Chruscicki D. A., Sutton S., Sutton L. Branch retinal artery occlusion associated with sildenafil citrate // Retinal Physician. 2011.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Dundar S., Ozkan S. Effect of sildenafil on ocular haemodynamics // Eye. 2001. № 15. Р. 507-510.</mixed-citation><mixed-citation xml:lang="en">Dundar S., Ozkan S. Effect of sildenafil on ocular haemodynamics // Eye. 2001. № 15. Р. 507-510.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">El-Domyati M., El-Fakahani H. et al. Non-arteriticischaemic optic neuropathy after 36 hours of intake of sildenafil citrate // Andrologia. 2009. № 41. Р. 319-321.</mixed-citation><mixed-citation xml:lang="en">El-Domyati M., El-Fakahani H. et al. Non-arteriticischaemic optic neuropathy after 36 hours of intake of sildenafil citrate // Andrologia. 2009. № 41. Р. 319-321.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Grunwald J. E., Siu K. K. et al. Effect of sildenafil citrate (Viagra) on the ocular circulation // Am. J. Ophthalmol. 2001. № 131. Р. 751-757.</mixed-citation><mixed-citation xml:lang="en">Grunwald J. E., Siu K. K. et al. Effect of sildenafil citrate (Viagra) on the ocular circulation // Am. J. Ophthalmol. 2001. № 131. Р. 751-757.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Hayreh S. S., Fraterrigo L, Jonas J. Central retinal vein occlusion associated with cilioretinal artery occlusion // Retina. 2008. № 28. Р. 581-594.</mixed-citation><mixed-citation xml:lang="en">Hayreh S. S., Fraterrigo L, Jonas J. Central retinal vein occlusion associated with cilioretinal artery occlusion // Retina. 2008. № 28. Р. 581-594.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Jagel H., Jagel C., Serely L. Visual short term effects of Viagra; Double blind study in healthy ypung subjects // Am. J. Ophthalmol. 2004. № 44. Р. 842-849.</mixed-citation><mixed-citation xml:lang="en">Jagel H., Jagel C., Serely L. Visual short term effects of Viagra; Double blind study in healthy ypung subjects // Am. J. Ophthalmol. 2004. № 44. Р. 842-849.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Klein R., Moss S. E., Klein B. E. The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study // Arch. Ophthalmol. 2008. № 126. Р. 513-518.</mixed-citation><mixed-citation xml:lang="en">Klein R., Moss S. E., Klein B. E. The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study // Arch. Ophthalmol. 2008. № 126. Р. 513-518.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kumar A., Kar S., Fay W. P. Thrombosis, physical activity, and acute coronary syndromes // J. Appl. Physiol. 2011. № 19. Р. 599-605.</mixed-citation><mixed-citation xml:lang="en">Kumar A., Kar S., Fay W. P. Thrombosis, physical activity, and acute coronary syndromes // J. Appl. Physiol. 2011. № 19. Р. 599-605.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kurtulan E., Gulcu A. et al. Effects of sildenafil on ocular perfusion demonstrated by color Doppler ultrasonography // Int. J. Inpor. Res. 2004. № 16. Р. 244-248.</mixed-citation><mixed-citation xml:lang="en">Kurtulan E., Gulcu A. et al. Effects of sildenafil on ocular perfusion demonstrated by color Doppler ultrasonography // Int. J. Inpor. Res. 2004. № 16. Р. 244-248.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Laties A., Sharlip I. Ocular safety in patients using sildenafil therapy for erectile dysfunction // J. Sex Med. 2006. № 3. Р. 12-27.</mixed-citation><mixed-citation xml:lang="en">Laties A., Sharlip I. Ocular safety in patients using sildenafil therapy for erectile dysfunction // J. Sex Med. 2006. № 3. Р. 12-27.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Nawaiseh B., Shobaki A. et al. Central retinal vein occlusion after sildenafil citrate (Viagra) use // JRMS. 2006. № 13 (1). Р. 46-47.</mixed-citation><mixed-citation xml:lang="en">Nawaiseh B., Shobaki A. et al. Central retinal vein occlusion after sildenafil citrate (Viagra) use // JRMS. 2006. № 13 (1). Р. 46-47.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Pepin S., Ian P. Stepwise decline in visual field after serial sildenafil use // J. Neuroophthalmol. 2008. № 28. Р. 76-77.</mixed-citation><mixed-citation xml:lang="en">Pepin S., Ian P. Stepwise decline in visual field after serial sildenafil use // J. Neuroophthalmol. 2008. № 28. Р. 76-77.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Querques G., Prascina F., Sarra G. M. et al. Combined central retinal vein and cilioretinalartery occlusion // Int. Ophthalmol. 2008. № 28. Р. 47-49.</mixed-citation><mixed-citation xml:lang="en">Querques G., Prascina F., Sarra G. M. et al. Combined central retinal vein and cilioretinalartery occlusion // Int. Ophthalmol. 2008. № 28. Р. 47-49.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Vicuna-Kojchtn J., Armer R., Chowers I. Sildenafil-associated consecutive nonarteritic anterior ischaemic optic neuropathy, cilioretinal artery occlusion, and central retinal vein occlusion in hemodialysis patient // Eye. 2006. № 21. Р. 127-129.</mixed-citation><mixed-citation xml:lang="en">Vicuna-Kojchtn J., Armer R., Chowers I. Sildenafil-associated consecutive nonarteritic anterior ischaemic optic neuropathy, cilioretinal artery occlusion, and central retinal vein occlusion in hemodialysis patient // Eye. 2006. № 21. Р. 127-129.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
